"Developed and supervised by Prof Pete Smith—one of Australia’s leading allergists and immunologists—Allergy Medical provides the most advanced and comprehensive allergy care available today. Our service has evolved from testing and diagnosis to complete allergy care and personalised support—including immunotherapy, eczema management and dietetics."

During the past decade, Allergy Medical conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Allergy Medical" are "Peanut Allergy" (2 trials). Many other conditions were trialed in "Allergy Medical" in a lesser frequency.

Most popular intervention types in "Allergy Medical" are "Biological" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (1 trials), "Viaskin Peanut 250mcg" (1 trials) and "Viaskin Peanut 250µg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Allergy Medical" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Allergy Medical". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Allergy Medical, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Allergy Medical, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".